Acute severe cardiac failure in a myeloma patient due to proteasome inhibitor bortezomib

Proteasome inhibitors: a novel class of potent and effective antitumor agents.

Julian Adams, Vito J. Palombella, Edward A. Sausville et al. · PubMed · 1999 · 1.5K citations

Medicine, Oncology, Pharmacology +14

Stabilization of p53 Is a Novel Mechanism for Proapoptotic Function of NF-κB

Shuichi Fujioka, Christian Schmidt, Guido M. Sclabas et al. · Journal of Biological Chemistry · 2004 · 135 citations · Full text

Life Sciences, Cell Biology, Oncology +15

Severe reversible cardiac failure after bortezomib treatment combined with chemotherapy in a non-small cell lung cancer patient: a case report

Jens Voortman, Giuseppe Giaccone · BMC Cancer · 2006 · 120 citations · Full text

Medicine, Oncology, Pharmacology +16

Differential Apoptotic Response to the Proteasome Inhibitor Bortezomib (VELCADE^TM, PS-341) in Bax-Deficient and p21-Deficient Colon Cancer Cells

Jian Yu, Sagarika Tiwari · Cancer Biology & Therapy · 2003 · 71 citations

Medicine, Oncology, Pharmacology +17

Final Report of Toxicity and Efficacy of a Phase II Study of Oral Cyclophosphamide, Thalidomide, and Prednisone for Patients with Relapsed or Refractory Multiple Myeloma: A Hoosier Oncology Group Trial, HEM01-21

Attaya Suvannasankha, Christopher A. Fausel, Beth E. Juliar et al. · The Oncologist · 2007 · 51 citations

Medicine, Pharmacology, Pharmacotherapy +17